Skip to main content

Table 1 Clinical and laboratory characteristics of the participants according to MSI status

From: Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer

Variables

MSI-H

MSS

P value

Number

64

366

 

Age (years)

59.4 ± 11.8

61.0 ± 9.4

0.328

Gender (female, %)

33 (51.6)

148 (40.4)

0.096

BMI (kg/m2)

24.5 ± 3.3

23.2 ± 3.2

0.004

Current smoker (%)

25 (39.1)

158 (43.2)

0.540

Drinker (n, %)

17 (26.6)

122 (33.3)

0.285

Creatinine (ÎĽmol/L)

80.9 ± 19.7

81.1 ± 18.4

0.929

CEA (ng/mL)

3.14 (1.57–7.98)

4.86 (2.15–12.12)

0.030

WBC (× 109/L)

8.07 ± 2.98

6.92 ± 2.30

0.004

Haemoglobin (g/L)

124.6 ± 27.3

134.3 ± 22.4

0.009

Platelet count (× 109/L)

309.6 ± 121.8

266.8 ± 82.6

0.008

AIM (ÎĽg/mL)

5.89 (1.37)

6.86 (1.49)

< 0.001

  1. Data are presented as means (SD) or median (interquartile range) or percentage
  2. BMI body mass index, CEA carcinoembryonic antigen, WBC white blood cells, AIM apoptosis inhibitor of macrophage